semaglutide hims review Wegovy® Pen Ozempic® | Hims

Telehealth: Revolutionizing Healthcare Accessibility Telehealth uses secure digital technology to connect patients with healthcare providers, offering care from virtually anywhere

Successful dietary management during semaglutide therapy requires attention to both what and how you consume foods and beverages

adults currently take a GLP-1 for weight loss (up from 3 percent in 2024 and 8 percent in 2025) 15 percent have used a GLP-1 medication for weight loss at some point 68 percent of current users take brand-name medications such as Ozempic, Wegovy, or Zepbound 19 percent take compounded or custom-mixed GLP-1 versions not approved by the FDA 91 percent of Americans now know GLP-1 drugs can be used for weight loss (up from 80 percent in 2024) The Medicare GLP-1 Bridge, administered by the Centers for Medicare and Medicaid Services (CMS), is a demonstration program operating outside the standard Part D benefit

Ask a healthcare practitioner before use if you are pregnant or breastfeeding, have kidney disease, or have a seizure disorder